LVTX
Price
$1.42
Change
+$0.02 (+1.43%)
Updated
Jul 18 closing price
Capitalization
37.35M
37 days until earnings call
TCRX
Price
$1.82
Change
-$0.07 (-3.70%)
Updated
Jul 18 closing price
Capitalization
102.99M
24 days until earnings call
Interact to see
Advertisement

LVTX vs TCRX

Header iconLVTX vs TCRX Comparison
Open Charts LVTX vs TCRXBanner chart's image
LAVA Therapeutics
Price$1.42
Change+$0.02 (+1.43%)
Volume$23.8K
Capitalization37.35M
TScan Therapeutics
Price$1.82
Change-$0.07 (-3.70%)
Volume$178.38K
Capitalization102.99M
LVTX vs TCRX Comparison Chart in %
Loading...
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LVTX vs. TCRX commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVTX is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (LVTX: $1.42 vs. TCRX: $1.82)
Brand notoriety: LVTX and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LVTX: 81% vs. TCRX: 27%
Market capitalization -- LVTX: $37.35M vs. TCRX: $102.99M
LVTX [@Biotechnology] is valued at $37.35M. TCRX’s [@Biotechnology] market capitalization is $102.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LVTX’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • LVTX’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, LVTX is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LVTX’s TA Score shows that 4 TA indicator(s) are bullish while TCRX’s TA Score has 6 bullish TA indicator(s).

  • LVTX’s TA Score: 4 bullish, 4 bearish.
  • TCRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than LVTX.

Price Growth

LVTX (@Biotechnology) experienced а +4.41% price change this week, while TCRX (@Biotechnology) price change was +0.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

LVTX is expected to report earnings on Aug 26, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($103M) has a higher market cap than LVTX($37.4M). LVTX YTD gains are higher at: 49.317 vs. TCRX (-40.132). LVTX has higher annual earnings (EBITDA): -26.26M vs. TCRX (-124.58M). TCRX has more cash in the bank: 252M vs. LVTX (66.6M). LVTX has less debt than TCRX: LVTX (312K) vs TCRX (97M). LVTX has higher revenues than TCRX: LVTX (4.99M) vs TCRX (4.42M).
LVTXTCRXLVTX / TCRX
Capitalization37.4M103M36%
EBITDA-26.26M-124.58M21%
Gain YTD49.317-40.132-123%
P/E RatioN/AN/A-
Revenue4.99M4.42M113%
Total Cash66.6M252M26%
Total Debt312K97M0%
TECHNICAL ANALYSIS
Technical Analysis
LVTXTCRX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 25 days ago
88%
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDP33.800.05
+0.15%
Fresh Del Monte Produce
TDG1597.302.05
+0.13%
TransDigm Group
SNAL1.47N/A
N/A
Snail
AMG209.95-0.77
-0.37%
Affiliated Managers Group
SGHT3.50-0.04
-1.13%
Sight Sciences

LVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LVTX has been loosely correlated with JBPHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LVTX jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVTX
1D Price
Change %
LVTX100%
+1.43%
JBPHF - LVTX
38%
Loosely correlated
N/A
TCRX - LVTX
35%
Loosely correlated
-3.70%
OPORF - LVTX
32%
Poorly correlated
N/A
AMLX - LVTX
30%
Poorly correlated
+0.72%
CRBU - LVTX
29%
Poorly correlated
+12.02%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with FATE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-3.70%
FATE - TCRX
46%
Loosely correlated
-1.74%
CRBU - TCRX
44%
Loosely correlated
+12.02%
MGNX - TCRX
44%
Loosely correlated
-3.90%
ABOS - TCRX
43%
Loosely correlated
+1.35%
EYPT - TCRX
41%
Loosely correlated
N/A
More